Oct 2026· Science· Vol 394 6819, pp.
53-59
· 0 citations· 88 references
Medicine
TL;DR
This Review integrates mechanistic advances in sex chromosome biology-including escape from X chromosome inactivation, X reactivation, parent-of-X-origin, X-skew, X- and Y-linked gene functions, and Y loss-with aging, neurologic disease, immunity, cancer, and cardiometabolic disease.
Abstract
Sex differences have traditionally been attributed to gonadal hormones, but accumulating evidence shows that sex chromosomes exert distinct, cell-autonomous effects on health, aging, and disease. XX and XY complements alter gene dosage, epigenetic programming, immune signaling, metabolism, and cellular stress responses, which shape aging and disease trajectories in women and men. This Review integrates mechanistic advances in sex chromosome biology-including escape from X chromosome inactivation, X reactivation, parent-of-X-origin, X-skew, X- and Y-linked gene functions, and Y loss-with aging, neurologic disease, immunity, cancer, and cardiometabolic disease. We highlight insights from mouse models, human studies, and emerging technologies that disentangle hormone-driven effects from chromosome-mediated effects and discuss translational implications for diagnostics, biomarkers, therapeutics, and clinical trial design, emphasizing the integration of sex chromosome biology into precision medicine.
Brain development requires precise spatiotemporal regulation of gene expression and molecular processes to establish healthy and functional neural circuits. Traditionally, sex differences in brain development have been attributed primarily to gonadal differentiation and the subsequent actions of sex hormones on develop...
Maria A. Tsiarli, Erica N. Larschan· Frontiers in Behavioral Neur...· 0 citations
A single-nucleus multi-omics analysis of the hypothalamus in young, middle aged, and aged male and female mice highlights distinct cell-type-specific aging trajectories in the male and female hypothalamus, identifies female aging signatures associated with X-linked epigenetic regulatory programs, and provides a compreh...
Dou-Dou Yu, I. Osipov, Lexi-Amber Hassell et al.· bioRxiv· 0 citations
Mosaic loss of the Y chromosome (mLOY) is a male‑specific somatic loss of the Y chromosome that is predominantly observed in peripheral blood leukocytes, but can also be found in other tissue types. It represents one of the most common male-specific somatic mutations, particularly prevalent in aging individuals. Accumu...
Qi Zhang, Jiang Yu, X. Zhai et al.· Protein & Cell· 0 citations
Alzheimer's disease (AD) exhibits marked sex differences in disease prevalence, progression, and therapeutic responsiveness, with women disproportionately affected by both cognitive decline and neuropathological burden. Although sex hormones such as estrogen, progesterone, and testosterone have demonstrated neuroprotec...
S. Supakul, Romruedee Phisalaphong, Makalin Changchai et al.· Stem Cells· 0 citations
Clinical heterogeneity remains a major challenge across human diseases, where patients with similar genetic backgrounds frequently exhibit striking differences in disease progression, therapeutic response and clinical outcome. Increasing evidence indicates that these differences cannot be explained by genetic variation...
Shahper Nazeer Khan, Danishuddin, Salamatu Tijjani Isah et al.· Biomolecules· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.